Alexandra Pender

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Peritoneal Dialysis

Ejection Fraction

Brain Metastases

Advanced Non Small Cell Lung Cancer

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Rohan Shotton, Rachel Broadbent, Alia Alchawaf, Mohamed Bakri Mohamed, Adam Gibb, Nicolás Martinez-Calle, Christopher Paul Fox, Mark Bishton, Alexandra Pender, Mary Gleeson, David Cunningham, Andrew John Davies, Sina Yadollahi, Toby Andrew Eyre, Graham P Collins, Faouzi Djebbari, Shireen Kassam, Paula Garland, Emily Watts, Wendy Osborne, William M Townsend, Rachael Pocock, Matthew J Ahearne, Fiona Miall, Xin Wang, Kim M Linton
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience. Blood advances (2023)
Rebekah Rittberg, Bonnie Leung, Aria Shokoohi, Alexandra Pender, Selina K Wong, Zamzam Al-Hashami, Ying Wang, Cheryl Ho
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy. Current oncology (Toronto, Ont.) 30 (6) (2023)
Rebekah Rittberg, Bonnie Leung, Aria Shokoohi, Alexandra Pender, Selina K Wong, Zamzam Al-Hashami, Ying Wang, Cheryl Ho
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy. Current oncology (Toronto, Ont.) 30 (6) (2023)
Rebekah Rittberg, Bonnie Leung, Aria Shokoohi, Alexandra Pender, Selina K Wong, Zamzam Al-Hashami, Ying Wang, Cheryl Ho
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy. Current oncology (Toronto, Ont.) 30 (6) (2023)
Rebekah Rittberg, Bonnie Leung, Aria Shokoohi, Alexandra Pender, Selina K Wong, Zamzam Al-Hashami, Ying Wang, Cheryl Ho
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy. Current oncology (Toronto, Ont.) 30 (6) (2023)
Alexandra Pender, Robin L Jones, Seth Pollack
Optimising Cancer Vaccine Design in Sarcoma. Cancers 11 (1) (2018)